BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 38326910)

  • 1. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
    Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
    Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prognostication and immunotherapy response prediction in esophageal squamous cell carcinoma using the DNA damage repair-associated signature.
    Zhang P; Wen B; Gong J; Liu Z; Zhang M; Zhou G; Zhang L; Zhang Z
    Environ Toxicol; 2024 May; 39(5):2803-2816. PubMed ID: 38287713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic stratification of sepsis through DNA damage response based RiskScore system: insights from single-cell RNA-sequencing and transcriptomic profiling.
    Lin Q; Zeng R; Yang J; Xu Z; Jin S; Wei G
    Front Immunol; 2024; 15():1345321. PubMed ID: 38404591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation.
    Liu P; Deng X; Zhou H; Xie J; Kong Y; Zou Y; Yang A; Li X
    Front Immunol; 2023; 14():1297180. PubMed ID: 38022619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma.
    Houlston R; Culliford R; Lawrence S; Mills C; Tippu Z; Chubb D; Cornish A; Browining L; Kinnersley B; Bentham R; Sud A; Pallikonda H; Frangou A; Gruber A; Litchfield K; Wedge D; Larkin J; Turajlic S
    Res Sq; 2023 Dec; ():. PubMed ID: 38106039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-ECM interactions control DDR.
    Dickreuter E; Cordes N
    Oncoscience; 2015; 2(8):679-80. PubMed ID: 26425656
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic reprogramming of clear cell renal cell carcinoma.
    Zhu H; Wang X; Lu S; Ou K
    Front Endocrinol (Lausanne); 2023; 14():1195500. PubMed ID: 37347113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.
    Kwok M; Agathanggelou A; Stankovic T
    Blood; 2024 May; 143(21):2123-2144. PubMed ID: 38457665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications.
    Jing X; Qin X; Liu H; Liu H; Wang H; Qin J; Zhang Y; Cao S; Fan X
    Eur J Med Res; 2024 Feb; 29(1):107. PubMed ID: 38326910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy.
    Ged Y; Chaim JL; DiNatale RG; Knezevic A; Kotecha RR; Carlo MI; Lee CH; Foster A; Feldman DR; Teo MY; Iyer G; Chan T; Patil S; Motzer RJ; Hakimi AA; Voss MH
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study.
    Xiao Y; Lu D; Lei M; Xie W; Chen Y; Zheng Y; Wang C; Zhao J; Zhu Z; Zhao X; Huang M; Lin Y; Li Z; Yang L
    Ann Transl Med; 2021 Nov; 9(22):1661. PubMed ID: 34988170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Damage Response Pathway Alteration in Locally Advanced Clear-Cell Renal-Cell Carcinoma Is Associated With a Poor Outcome.
    Na JC; Nagaya N; Rha KH; Han WK; Kim IY
    Clin Genitourin Cancer; 2019 Aug; 17(4):299-305.e1. PubMed ID: 31204211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current evidence on surgical management for synchronous bilateral renal tumors: results from a scoping review.
    Giulioni C; Maggi M; Pirola GM; Martorana E; Cormio A; Teoh JY; Gauhar V; Galosi AB; Castellani D
    World J Urol; 2023 Aug; 41(8):2107-2118. PubMed ID: 37405465
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.